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Abstract
Background: Apigenin is a non-toxic natural flavonoid that is abundantly present in common fruits and vegetables. It has
been reported that apigenin has various beneficial health effects such as anti-inflammation and chemoprevention. Multiple
studies have shown that inflammation is an important risk factor for atherosclerosis, diabetes, sepsis, various liver diseases,
and other metabolic diseases. Although it has been long realized that apigenin has anti-inflammatory activities, the
underlying functional mechanisms are still not fully understood.
Methodology and Principal Findings: In the present study, we examined the effect of apigenin on LPS-induced
inflammatory response and further elucidated the potential underlying mechanisms in human THP-1-induced macrophages
and mouse J774A.1 macrophages. By using the PrimePCR array, we were able to identify the major target genes regulated
by apigenin in LPS-mediated immune response. The results indicated that apigenin significantly inhibited LPS-induced
production of pro-inflammatory cytokines, such as IL-6, IL-1b, and TNF-a through modulating multiple intracellular signaling
pathways in macrophages. Apigenin inhibited LPS-induced IL-1b production by inhibiting caspase-1 activation through the
disruption of the NLRP3 inflammasome assembly. Apigenin also prevented LPS-induced IL-6 and IL-1b production by
reducing the mRNA stability via inhibiting ERK1/2 activation. In addition, apigenin significantly inhibited TNF-a and IL-1b-
induced activation of NF-kB.
Conclusion and Significance: Apigenin Inhibits LPS-induced Inflammatory Response through multiple mechanisms in
macrophages. These results provided important scientific evidences for the potential application of apigenin as a
therapeutic agent for inflammatory diseases.
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Introduction
Lipopolysaccharide (LPS), a major component of gram-negative
bacteria cell membrane, is a well-characterized inducer of the
inflammatory response. The initial acute innate immune response
to LPS primes the adaptive immune system against further
infection [1]. Macrophages are the major players in both innate
and adaptive inflammatory responses. It has been well-recognized
that the prolonged activation of the inflammatory response
contributes to a wide variety of chronic human diseases such as
arteriosclerosis, sepsis, obesity, diabetes, various liver diseases,
inflammatory bowel disease, autoimmune diseases, allergy and
cancer [2,3]. Activation of macrophages by LPS leads to the
increased secretion of a large set of proinflammatory cytokines,
such as tumor necrosis factor (TNF)-alpha, interleukin (IL)-1, IL-6,
and macrophage chemoattractant protein-1 (MCP-1). Persistent
production of these proinflammatory cytokines can cause severe
tissue destruction and eventually organ failure. The traditional
steroidal anti-inflammatory drugs (SAIDs) and nonsteroidal anti-
inflammatory drugs (NSAIDs) are the commonly used to treat
acute inflammatory disorders. However, these conventional drugs
have not been successful in treating chronic inflammatory diseases
due to severe side effects [4]. The need for the development of new
anti-inflammatory drugs with higher potency and lower toxicity is
urgent to combat various complex inflammatory diseases.
Flavonoids are a family of polyphenolic compounds, that are
widely distributed in the plant kingdom and consumed in
significant amounts as part of the human diet [5]. The beneficial
effects of these flavonoids to human health have been well-
documented [5–12]. Epidemiological studies have shown that
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flavonoids in a healthy diet have potentially beneficial effects in
inflammatory diseases and can reduce the risk of various cancers
[13]. Apigenin (49, 5, 7,-trihydroxyflavone) (Fig.1) is a non-toxic
and non-mutagenic dietary flavonoid, which is abundantly present
in common fruits and vegetables, such as oranges, grapefruits,
parsley, onions, chamomile, wheat sprouts, and some seasonings
[13,14]. During last decade, apigenin has garnered increased
interest as a health promoting agent because of its low intrinsic
toxicity and high chemopreventive efficiency [13,14]. It has been
shown that apigenin induces human pancreatic cancer cell death
via inhibition of the glycogen synthase kinase-3b/nuclear factor
kappa B (NF-kB) signaling pathway [15]. In addition, apigenin has
been reported to have anti-inflammatory activities. It protects
endothelial cells from LPS-induced inflammation and inhibits
allergen-induced airway inflammation [16,17]. Several intracellu-
lar signaling pathways have been suggested to be involved in
apigenin-mediated anti-inflammatory effects, such as NF-kB,
MAPK/ERK, and JNK pathways [18,19]. However, the cellu-
lar/molecular mechanisms by which apigenin modulates LPS-
induced inflammatory response in macrophages have not been
fully revealed.
In the present study, we examined the effect of apigenin on
LPS-induced inflammatory response in macrophages and further
explored the potential cellular/molecular mechanisms involved in
its anti-inflammatory effects.
Methods
Materials
Apigenin, LPS, phorbol 12-myristate 13-acetate (PMA), actino-
mycin D, and hygromycin B were purchased from Sigma-Aldrich
(St. Louis, MO). Cell Counting Kit-8 (CCK-8) was from Dojindo
Molecular Technologies (Kumamoto, Japan). Antibodies against
IL-1b, p-ERK1/2, ERK1, ERK2 and ASC were from Santa Cruz
Biotechnology (Santa Cruz, CA). Antibody against caspase-1 was
from Millipore Corporation (Billerica, MA). Mouse monoclonal
Figure 1. The chemical structure of apigenin.
doi:10.1371/journal.pone.0107072.g001
Table 1. Real-time PCR primers.
Gene Forward Primer (59-39) Reverse Primer (59-39)
hGAPDH ACATCATCCCTGCCTCTACTGG TCCGACGCCTGCTTCACC
hIL-1b TGGCTTATTACAGTGGCAATG GTGGTGGTCGGAGATTCG
hIL-6 CAGATTTGAGAGTAGTGAGGAAC CGCAGAATGAGATGAGTTGTC
TNF-a CGAGTCTGGGCAGGTCTAC GGGAGGCGTTTGGGAAGG
hCaspase-1 CCACATCCTCAGGCTCAGAAG GCGGCTTGACTTGTCCATTATTG
hNLRP3 AGGAAGATGATGTTGGACTGG GTGGATGGGTGGGTTTGG
mGAPDH GTCGTGGATCTGACGTGCC GATGCCTGCTTCACCACCTT
mIL-1b AATCTCACAGCAGCACATC AGCAGGTTATCATCATCATCC
mIL-6 GAGGATACCACTCCCAACAGACC AAGTGCATCATCGTTGTTCATACA
mTNF-a GCCTCCCTCTCATCAGTTC ACTTGGTGGTTTGCTACG
doi:10.1371/journal.pone.0107072.t001
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antibody against b-actin and NLRP3 polyclonal antibody were
from Thermo Scientific (Wilmington, DE). IRDye secondary
antibodies were purchased from LI-COR Biosciences (Lincoln,
NE). Recombinant human/mouse IL-1b, IL-6 and TNF-a, anti-
human/mouse IL-1b, IL-6 and TNF-a antibodies, biotinylated
anti-human/mouse IL-1b, IL-6 and TNF-a antibodies, and
avidin-HRP were from eBioscience (San Diego, CA). Immune
Response Tier 1 H96 Plate, Bio-Rad protein assay reagent,
Precision Plus Kaledoscope Standards, iQTM SYBR Green
Supermix were obtained from Bio-Rad (Hercules, CA). QIAzol
Lysis Reagent was obtained from QIAGEN Sciences (German-
town, MD). High Capacity cDNA Reverse Transcription Kit was
from Life Technologies (Grand Island, NY). FuGene HD
transfection Reagent, pGL4.32 [luc2P/NF-kB- RE/Hygro] vector
and pGL4.76 [hRluc/Hygro] vector were from Promega (Mad-
sion, WI).
Cell culture and treatment
Human THP-1 monotypic cells (from ATCC, Cat# TIB-
202TM) were cultured in RPMI 1640 medium supplemented with
10% FBS, 100 U/mLmL penicillin, and 100 mg/mL streptomycin
at 37uC with 5% CO2. THP-1 monocytes were treated with PMA
(100 ng/mL) for 5 days to induce differentiation into macrophag-
es. Mouse J774A.1 macrophages (from ATCC, Cat# TIB-67TM)
were maintained in DMEM supplemented with 10% FBS, 100 U/
mL penicillin, and 100 mg/mL streptomycin at 37uC with 5%
CO2. Cells from passages 12 to 15 were used in these studies.
HEK293 cells were cultured in DMEM supplemented with 10%
FBS, 0.1 mM non-essential amino acid and 1% Penicillin-
Streptomycin. Apigenin was dissolved in dimethyl sulfoxide
(DMSO) and directly added into the culture medium. Based on
the preliminary toxicity test and previous published studies
[20,21], the concentrations of apigenin used in this study were
6.25, 12.5 and 25 mM. For each result, a minimum of three
independent experiments were performed.
Immune response PrimerPCR assay
Human THP-1-derived macrophages were pretreated with
apigenin (25 mM) for 2 h and then treated with LPS (100 ng/mL)
for 24 h. Total cellular RNA was isolated using QIAzol Lysis
Reagent and reverse transcribed into the first-strand cDNA using
a High-Capacity cDNA Transcription Kit as described previously
[22]. The 20 ng of cDNA of control or LPS- or LPS + apigenin-
treated samples were loaded into the Immune Response Tier 1
H96 plate. The mRNA levels of 91 genes involved in the
inflammatory immune response were detected at the same time
using iQTM SYBR Green Supermix on Bio-Red CFX96 real-
time PCR system. The data were analyzed by using Bio-Rad CFX
manager software.
Figure 2. The clustergram of PrimePCR assay in human THP-1-
derived macrophages. Cells were pretreated with apigenin (A,
25 mM) or DMSO for 2 h, and then treated with LPS (100 ng/mL) or
vehicle control for 24 h. Total cellular RNA was isolated and reverse
transcribed. The mRNA levels of 91 genes involved in the inflammatory
immune response were detected using a pre-designed PrimePCR assay
following the manufacturer’s instructions. The results were analyzed
using Bio-Rad CFX manager software. The clustergram of all the tested
genes is shown.
doi:10.1371/journal.pone.0107072.g002
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RNA isolation and quantitative real-time RT-PCR
Cells were pretreated with apigenin for 2 h and then treated
with LPS (100 ng/mL) or vehicle control for 24 h. Total Cellular
RNA was isolated using QIAzol Lysis Reagent and reverse
transcribed into first-strand cDNA using a High-Capacity cDNA
Transcription Kit. The mRNA levels of IL-1b, IL-6, TNF-a,
caspase-1, ASC, NLRP3 and GAPDH were quantified using gene-
specific primers (Table 1). iQTM SYBR Green Supermix was
Figure 3. The clustergram of the major target genes of apigenin in human THP-1-derived macrophages. Cells were pretreated with
apigenin (A, 25 mM) or DMSO for 2 h, and then treated with LPS (100 ng/mL) or vehicle control for 24 h. Total cellular RNA was isolated and reverse
transcribed. The mRNA levels of 91 genes involved in an inflammatory immune response were detected using a pre-designed PrimePCR assay
following the manufacturer’s instructions. The results were analyzed using Bio-Rad CFX manager software. The clustergram of major target genes is
shown.
doi:10.1371/journal.pone.0107072.g003
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used as a fluorescent dye to detect the presence of double-stranded
DNA. The mRNA levels of target genes were quantified with real-
time RT-PCR as described previously [22].
Enzyme-Linked Immunosorbent Assay (ELISA)
Cells were pretreated with apigenin for 2 h and then treated
with LPS (100 ng/mL) or vehicle control for 24 h. At the end of
the treatment, cell culture media were collected and centrifuged at
14,0006 rpm for 1 min. The protein levels of TNF-a, IL-1b, and
IL-6 in the media were determined by ELISA as described
previously [22]. The total protein concentrations of the viable cells
were determined using Bio-Rad protein assay reagent. The protein
levels of the TNF-a, IL-1b, and IL-6 in media were normalized to
the total protein amount of the viable cells and expressed as pg/
mg proteins.
Assessment of IL-1b and IL-6 mRNA stability
Cells were pretreated with apigenin for 2 h and then treated
with LPS (100 ng/mL) or vehicle control for 2 h before addition of
actinomycin D (5.0 mg/mL, time 0). The cells were harvested for
isolation of total cellular RNA at 0.5, 1, 2, 4 and 6 h after addition
of actinomycin D. The mRNA stability of IL-1b and IL-6 were
quantified with real-time PCR as described previously [23].
Western blot analysis
Total cell lysates were prepared as previously described [24].
The protein concentration was determined using Bio-Rad protein
assay reagent. A total of 70 mg of proteins was resolved on 10%
Bis–Tris gels and transferred to nitrocellulose membranes. The
protein levels of target genes were detected using specific primary
antibodies and IRDye secondary antibodies on Odyssey Fluores-
cence Imaging System (LI-COR Biosciences, USA). The density of
the immunoblots was analyzed using Odyssey V3.0 software and
normalized with b-Actin.
Immunofluorescence staining of ASC
Human THP-1-derived macrophages were cultured on 22622-
mm glass coverslips in 6-well plates. Cells were pretreated with
apigenin (25 mM) for 2 h and then treated with LPS (100 ng/ml)
or vehicle control for 24 h. Cells were fixed with 3.7%
formaldehyde in PBS for 30 min, permeabilized with 0.1%
Triton-X-100 for 3 min, and blocked with 3% normal goat serum
for 1 h. Rabbit anti-ASC antibody was incubated for 4 h at RT.
The negative control was incubated with the same amount of
normal rabbit IgG. The Alexa Fluor 488-labeled goat anti-rabbit
antibody was incubated for 1 h at RT. The coverslips were
mounted with fluorescence mounting medium with DAPI. The
intracellular ASC speck formation was visualized under an
Olympus 1671 fluorescence microscope with a 60x oil objective
using a dual-filter set for FITC and DAPI. The images were
captured using IPLab 4.0 software.
Measurement of NF-kB activity
NF-kB activity was detected using a NF-kB-luciferase reporter
vector, pGL4.32 [luc2P/NF-kB-RE/Hygro]. It contains five
copies of a NF-kB response element (NF-kB-RE) that drives the
transcription of the luciferase reporter gene luc2P (Photinus
pyralis). Briefly, 293 cells were transfected with pGL4.32 [luc2P/
NF-kB-RE/Hygro] or pGL4.76 [hRluc/Hygro] using FuGene
HD transfection reagent. The stably transfected cells were selected
by Hygromycin B (100 mg/mL) for two weeks. To determine the
effect of apigenin on inflammatory cytokine-mediated activation of
NF-kB, 293 cells expressing NF-kB-RE were pretreated with
apigenin for 2 hours, and then treated with human IL-1b (10 ng/
mL) or TNF-a (10 ng/mL), or vehicle control for 4 hours. The
luciferase activity was detected on a Glomax Multi-functional
Plate Reader (Promega) using the Promega Luciferase Assay
System kit according to manufacturer’s instructions. The relative
luciferase activity of each group was compared to control vehicle.
Statistical analysis
All of the experiments were repeated at least three times and the
data were expressed as mean 6 SD. One-way ANOVA was
employed to analyze the differences between sets of data. To
confirm the differences occurred between groups, post hoc tests
were used for follow-up test. Statistics were performed using
GraphPad Prism 5.0 (GraphPad, San Diego, CA). A value of p,
0.05 was considered statistically significant.
Results
Identification of the target genes regulated by apigenin
in LPS-mediated immune response in macrophages
Although apigenin has been reported to have anti-inflammatory
activities and is able to inhibit the expression of several
proinflammatory cytokines such as TNF-a and IL-6, there is no
information available regarding the effect of apigenin on LPS-
induced immune response. In order to determine the effect of
apigenin on LPS-induced inflammatory response and identify the
specific target genes, we did the quantitative real-time PrimePCR
array using the Bio-Rad predesigned assay specifically for
inflammatory immune response. The differentiated THP-1
macrophages were pretreated with apigenin (25 mM) for 2 h and
then treated with LPS (100 ng/mL) or vehicle control for 24 h.
Total cellular RNA was isolated and reverse transcribed into first-
strand cDNA. A total of 20 ng of cDNA was used to run a real-
time PrimePCR array according to the protocol recommended by
the manufacturer. The results indicated that in LPS-stimulated
macrophages, more than two dozen genes were significantly up-
regulated including IL-6, IL-8, IL1b, IL12b, NFKBIA (nuclear
factor of kappa light polypeptide gene enhancer in B-cells inhibitor
alpha), and NFKB1. But IL-10 and TLR4 were significantly
down-regulated (Fig.2).
Cytokines are important immunomodulation agents in regulat-
ing host responses to infection, inflammation, sepsis, and cancer
[25]. As shown in Fig.3, apigenin not only significantly inhibited
LPS-induced up-regulation of pro-inflammatory cytokines, such as
IL-1b, IL-6, and IL-12b, but also reduced LPS-induced increase of
inflammatory chemokine CCL5 and adhesion molecules (ICAM1
and VCAM1). In addition, LPS-induced down-regulation of IL-10
was reversed by apigenin. These results suggest that apigenin may
Figure 4. Effect of apigenin on LPS-induced proinflammatory cytokines mRNA expression in human THP-1-derived macrophages.
Cells were pretreated with different concentrations of apigenin (A, 6.25, 12.5,25 mM) for 2 h, then treated with LPS (100 ng/mL) for 24 hours. Total
cellular RNA was isolated and reverse transcribed. The relative mRNA levels of IL-1b, IL-6, and TNF-a were detected by real-time RT-PCR as described
under ‘‘Methods’’. Values are mean 6 S.E. of three independent experiments. Statistical significance relative to vehicle control, ##p,0.01; ###p,
0.001; Statistical significance relative to LPS group, *p,0.05, **p,0.01, ***p,0.001. A. IL-1b; B. IL-6; C. TNF-a.
doi:10.1371/journal.pone.0107072.g004
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Figure 5. Effect of apigenin on LPS-induced proinflammatory cytokines mRNA expression in mouse J774A.1 macrophages. Cells
were pretreated with different concentrations of apigenin (A, 6.25, 12.5,25 mM) for 2 h and then treated with LPS (100 ng/mL) for 24 hours. Total
cellular RNA was isolated and reverse transcribed. The relative mRNA levels of IL-1b, IL-6, and TNF-a were detected by real-time RT-PCR as described
under ‘‘Methods’’. Values are mean 6 S.E. of three independent experiments. Statistical significance relative to vehicle control, ##p,0.01; ###p,
0.001; Statistical significance relative to LPS group, **p,0.01, ***p,0.001. A. IL-1b; B. IL-6; C. TNF-a.
doi:10.1371/journal.pone.0107072.g005
Anti-Inflammatory Effect of Apigenin
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modulate LPS-induced inflammatory response through multiple
mechanisms.
Effect of apigenin on LPS-induced expression of pro-
inflammatory cytokines in macrophages
In order to verify the results of PrimePCR Array and confirm
the anti-inflammatory effect of apigenin in macrophages, we
measured the mRNA levels of several key pro-inflammatory
cytokines involved in inflammatory response including IL-1b,
TNF-a, and IL-6 using real-time RT-PCR [22,26,27]. As shown
in Fig.4, LPS markedly increased mRNA levels of IL-1b, IL-6 and
TNF-a in human THP-1-derived macrophages, which were
completely inhibited by apigenin in a dose-dependent manner.
Similarly, apigenin also markedly inhibited LPS-induced expres-
sion of IL-1b, IL-6, and TNF-a in a dose-dependent manner in
mouse J774A.1 macrophages (Fig.5).
Effect of apigenin on LPS-induced secretion of IL-6, TNF-a
and IL-1b protein in macrophages
In order to determine whether the inhibition of the mRNA
expression of pro-inflammatory cytokines by apigenin is correlated
to the reduction of protein levels, we measured the TNF-a and IL-
Figure 6. Effect of apigenin on LPS-induced IL-6 and TNF-a protein expression in human THP-1-derived macrophages. Cells were
pretreated with different concentrations of apigenin (A, 6.25, 12.5,25 mM) for 2 h and then treated with LPS (100 ng/mL) for 24 h. At the end of
treatment, each cell culture medium was collected. The protein levels of IL-6 and TNF-a were determined by ELISA as described under ‘‘Methods’’.
Values are mean 6 S.E. of three independent experiments. Statistical significance relative to vehicle control, ###p,0.001; Statistical significance
relative to LPS group, **p,0.01, ***p,0.001. A. IL-6; B.TNF-a.
doi:10.1371/journal.pone.0107072.g006
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6 secreted into cell culture media using ELISA. As shown in Fig.6,
apigenin significantly reduced LPS-induced secretion of IL-6 in
human THP-1-derived macrophages. However, apigenin was less
potent in regulating TNFa expression. Similar results were
obtained using mouse J774A.1 macrophages (Fig.7).
The mature IL-1b production is rigorously controlled by
expression, maturation and secretion. The pro-inflammatory
stimuli induces expression of the inactive IL-1b precursor (pro-
IL-1b), which lacks a classic signal peptide and is further processed
into mature active IL-b by an intracellular cysteine protease,
caspase-1, and secreted from the cell [28,29]. To determine
whether apigenin had any effect on pro-IL-1b protein expression
and IL-1b maturation, we measured the intracellular pro-IL-1b
protein levels by Western blot analysis and the secreted mature IL-
1b protein levels in culture media by ELISA. As shown in
Fig.8A and B, LPS significantly increased pro-IL-1b protein levels,
but apigenin had no inhibitory effect on pro-IL-1b protein
expression. However, the LPS-induced secretion of mature IL-1b
was dose-dependently inhibited by apigenin in human THP-1-
derived macrophages (Fig.8C). These results suggest that apigenin
may regulate the maturation of IL-1b by targeting intracellular
caspase-1.
Figure 7. Effect of apigenin on LPS-induced IL-6 and TNF-a protein expression in in mouse J774A.1 macrophages. Cells were
pretreated with different concentrations of apigenin (A, 6.25, 12.5,25 mM) for 2 h and then treated with LPS (100 ng/mL) for 24 h. At the end of
treatment, each cell culture medium was collected. The protein levels of IL-6 and TNF-a were determined by ELISA as described under ‘‘Methods’’.
Values are mean 6 S.E. of three independent experiments. Statistical significance relative to vehicle control, ###p,0.001; Statistical significance
relative to LPS group, **p,0.01, ***p,0.001. A. IL-6; B.TNF-a.
doi:10.1371/journal.pone.0107072.g007
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Figure 8. Effect of apigenin on LPS-induced IL-1b protein expression and maturation in human THP-1-derived macrophages. Cells
were pretreated with apigenin (A, 6.25, 12.5, 25 mM) for 2 h and then treated with LPS (100 ng/mL) for 24 h. The Pro-IL-1b protein level was detected
by Western blot analysis. b-Actin was used as a loading control. The mature IL-1b protein level was detected by ELISA as described under ‘‘Methods’’.
Values are mean 6 S.E. of three independent experiments. Statistical significance relative to vehicle control, ###p,0.001; Statistical significance
relative to LPS group, ***p,0.001. A. Representative immunoblots of Pro-IL-1b and b-Actin; B. The relative protein levels of pro-IL-1b were analyzed
using Odyssey V3.0 software. C. Mature IL-1b level in the media.
doi:10.1371/journal.pone.0107072.g008
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Effect of apigenin on caspase-1 activation in LPS-treated
macrophages
Caspase-1 belongs to a family of nine cysteine proteases and is
involved in regulating the inflammatory response by cleaving the
precursors of several cytokines including IL-1b and IL-18. The
activation of caspase-1 is the rate-limiting step in IL-1b-mediated
inflammatory response. The activation of pro-caspase-1 results in
the generation of the active tetrameric caspase-1 p20 and p10
fragments [28,30–32]. In order to determine if apigenin exerts its
effect on IL-1b maturation through regulating caspase-1 expres-
sion or activation, we first determined the effect of apigenin on
LPS-induced mRNA expression of caspase-1. As shown in Fig. 9,
LPS significantly increased the mRNA levels of caspase-1, which
was completed inhibited by apigenin. The Western blot results
further indicated that LPS not only increased the total caspase-1
protein expression, but also increased the processing of pro-
caspase-1 into the active form (Fig. 10). However, apigenin had
less effect on total caspase-1 protein levels. Consistent with the
effect of apigenin on LPS-induced IL-1b maturation, apigenin
significantly reduced LPS-induced activation of caspase-1 at the
concentrations of 12.5 and 25 mM.
Effect of apigenin on LPS-induced activation of
inflammasome in macrophages
The production of mature IL-1b depends on the formation of
NLRP3 inflammasome, which is a multi-protein complex and
comprised of a NLRP3 sensor, an ASC/PYCARD adaptor and
caspase-1 [33]. LPS-induced activation of pro-caspase-1 requires
the formation of a functional NLRP3 inflammasome [34,35]. In
order to determine whether apigenin had any effect on the NLRP3
inflammasome, we measured the mRNA and protein levels of
NLRP3 and ASC. As shown in Fig.11, LPS had no significant
effect on NLRP3 and ASC/PYCARD expression. While apigenin
reduced the mRNA level of ASC/PYCARD at the 25 mM
concentration, the protein levels of ASC and NLRP3 remained
unchanged. To further elucidate the potential mechanism by
which apigenin inhibits LPS-induced maturation of IL-1b, we
examined the effect of apigenin on the assembly of the NLRP3
inflammasome. The human THP-1-derived macrophages were
pretreated with apigenin (25 mM) for 2 h, and then treated with
LPS (100 ng/ml) for 24 h. The formation of ASC specks was
monitored using immunofluorescence staining with a specific
antibody against ASC. As shown in Fig.12, LPS significantly
induced the formation of ASC specks; however, pretreatment of
the cells with apigenin significantly prevented the LPS-induced
increase in the formation of ASC specks. These results suggest that
apigenin inhibits the oligomerization of ASC and thus, interferes
with the assembly of a functional inflammasome.
Effect of apigenin on stability of IL-6 mRNA in LPS-
treated macrophages
Post-transcriptional regulation is a major control point for the
expression of many inflammatory cytokines with short half-lives
including IL-6 and IL-1b [36,37]. Our previous studies have
shown that Berberine inhibits HIV protease inhibitor-induced IL-
6 expression through regulating its mRNA stability in macro-
phages [23]. In order to identify the other potential mechanisms
by which apigenin inhibits LPS-induced IL-6 and IL-1b expres-
sion in macrophages, we examined the effect of apigenin on
stability of IL-6 and IL-1b mRNA in LPS-stimulated human
THP-1-derived macrophages. As shown in Fig.13, apigenin
significantly inhibited LPS-induced increase of IL-6 and IL-1b
mRNA stability. Similar results were obtained in mouse J774A.1
macrophages (Fig.14).
Effect of apigenin on ERK1/2 phosphorylation and NF-kB
activation
MAPK-mediated signaling pathways play critical roles in LPS-
induced proinflammatory cytokine production [38]. In macro-
phages, LPS activates ERK1/2, p38 MAPK, and Jun N-terminal
kinase (JNK) [38]. Activation of ERK1/2 has been shown to
promote LPS-induced IL-6 production [39]. Our previous studies
Figure 9. Effect of apigenin on LPS-induced caspase-1 mRNA expression in mouse J774A.1 macrophages. Cells were pretreated with
different concentrations of apigenin (A, 6.25, 12.5,25 mM) for 2 h and then treated with LPS (100 ng/mL) for 24 hours. Total cellular RNA was isolated
and reverse transcribed. The relative mRNA level of caspase-1 was detected by real-time RT-PCR as described under ‘‘Methods’’. Values are mean 6
S.E. of three independent experiments. Statistical significance relative to vehicle control, ##p,0.01;###p,0.001; Statistical significance relative to
LPS group, **p,0.01, ***p,0.001.
doi:10.1371/journal.pone.0107072.g009
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Figure 10. Effect of apigenin on caspase-1 activation in human THP-1-derived macrophages. Cells were pretreated with apigenin (A,
6.25, 12.5, 25 mM) for 2 h and then treated with LPS (100 ng/mL) for 24 h. Total cell lysates were prepared for Western blot analysis for caspase-1
protein level as described under ‘‘Methods’’. b-Actin was used as a loading control. The relative protein levels of caspase-1 were normalized to b-Actin
and analyzed using Odyssey V3.0 software. Values are mean 6 S.E. of three independent experiments. Statistical significance relative to vehicle
control, ###p,0.001; Statistical significance relative to LPS group, *p,0.05, **p,0.01, ***p,0.001. A. Representative immunoblots of Pro-caspase-
1 and active caspase-1 p20. B. The relative protein levels of total caspase-1. C. The relative protein levels of active caspase-1.
doi:10.1371/journal.pone.0107072.g010
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Figure 11. Effect of apigenin on the mRNA and protein expression of ASC and NLRP3 in human THP-1-derived macrophages. Cells
were pretreated with apigenin (A, 6.25, 12.5, 25 mM) for 2 h and then treated with LPS (100 ng/mL) for 24 h. Total cellular RNA was isolated and
reverse transcribed. The relative mRNA levels of PYCARD/ASC and NLRP3 were detected by real-time RT-PCR, as described under ‘‘METHODS’’. Values
are mean6 S.E. of three independent experiments. Statistical significance relative to LPS group,#p,0.05. A. The mRNA level of PYCARD/ASC; B. The
mRNA levels of NLRP3. C. The protein levels of ASC and NLRP3 were detected by Western blot analysis as described under ‘‘EXPERIMENTAL
PROCEDURES’’. The representative images of ASC and NLRP3 are shown.
doi:10.1371/journal.pone.0107072.g011
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also showed that ERK activation is responsible for HIV protease
inhibitor-induced IL-6 expression in macrophages [22]. It also has
been reported that several flavonoids inhibit LPS-induced
inflammatory response through inhibiting ERK1/2 activation
[40–44]. As shown in Fig.15, LPS-induced ERK activation was
inhibited by apigenin in humanTHP-1-derived macrophages.
Another control point of proinflammatory gene expression is the
NF-kB activation [45]. Inhibition of NF-kB activation represents
an important mechanism by which flavonoids inhibit LPS-induced
production of proinflammatory cytokines such as TNF-a, IL-6 and
IL-1b [44]. In order to determine whether NF-kB is also the target
of apigenin, HEK293 cells were stably transfected with a luciferase
reporter, which contains five copies of an NF-kB response
element. As shown in Fig.16, both IL-1b and TNF-a significantly
activated the NF-kB, which was inhibited by apigenin in a dose-
dependent manner. In the cells stably transfected with the
luciferase control vector, IL-1b and TNF-a had no effect on
luciferase activity (Data not shown).
Discussion
The principle findings of this study elucidated the important
cellular mechanisms underlying the anti-inflammation effect of
apigenin, a natural flavonoid. Apigenin inhibits LPS-induced
inflammatory response by i) modulating inflammasome assembly;
ii) reducing the mRNA stability; iii) inhibiting ERK1/2 and NF-
kB activation in macrophages.
Macrophages are the most important immune cells involved in
the inflammatory response. Macrophages can be activated by
many invaders, such as bacteria and virus, and activated
macrophages can produce numerous proinflammatory cytokines.
Although the acute inflammatory response helps restore cellular
homeostasis, prolonged activation of the inflammatory response
will result in severe tissue injury and organ failure [46]. Chronic
inflammation is an important risk factor for various human
diseases. Targeting reduction of chronic inflammation is an
effective strategy to prevent pathological progression of chronic
diseases. Flavonoids are the most commonly found polyphenol
compounds in fruits and vegetables. Epidemiological studies have
shown that high intake of diets rich in flavonoids can prevent
many chronic diseases including cardiovascular disease, metabolic
disease, allergy, and cancer [9,47–50]. A variety of mechanisms
have been proposed by which flavonoids prevent and attenuate
inflammatory responses and serve as possible cardioprotective,
neuroprotective and chemopreventive agents [8,9,11,47,48,51–
53]. Apigenin has been reported as an important dietary flavonoid
with strong chemopreventive and anti-inflammatory activities [13–
19]. Previous studies reported that apigenin significantly decreased
TNF-a, IL-6, and IL-1b mRNA levels in LPS-activated mouse
J774.2 macrophages [54]. However, the cellular/molecular
mechanisms by which apigenin inhibits the inflammatory response
remain to be fully identified.
In the present study, we were able to identify the major target
genes regulated by apigenin in the LPS-induced inflammatory
response in macrophages by using the newly developed PrimePCR
array. The results indicated that apigenin not only inhibited LPS-
induced increase of the major pro-inflammatory cytokines IL-1b
Figure 12. Effect of apigenin on LPS-induced oligomerization of ASC in human THP-1-derived macrophages. Cells were pretreated
with apigenin (A, 25 mM) for 2 h and then treated with LPS (100 ng/mL) for 24 h. Cells were fixed and analyzed for ASC expression using
immunofluorescence staining, as described under ‘‘METHODS’’. The representative images for each treatment are shown.
doi:10.1371/journal.pone.0107072.g012
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and IL-6, chemokine CCL-5 and two adhesion molecules ICAM-1
and VCAM-1, but also prevented LPS-induced decrease of anti-
inflammatory cytokine IL-10 (Fig.2–5). The cytotoxicity study
indicated that Apigenin had no toxic effect on macrophages at a
dose of 25 mM (Data not shown). By using both human and mouse
macrophages, we were able to identify the important mechanisms
underlying apigenin’s anti-inflammatory activities. As shown in
Figs. 4–7, we first demonstrated that apigenin specifically targets
ASC and interferes with the NLRP3 inflammasome formation and
subsequently inhibits caspase-1 activation in macrophages.
NLRP3 inflammasome-mediated production of mature IL-1b
has been recently identified as a critical mediator in the disease
progression of a variety of metabolic diseases [55]. IL-1b functions
as a master cytokine that can further induce the expression of
other pro-inflammatory cytokines, such as IL-6 and TNF-a,
chemokines, adhesion molecules and other inflammation-associ-
ated molecules to amplify the inflammatory response [29].
Figure 13. Effects of apigenin on LPS-mediated mRNA
stabilization in human THP-1-derived macrophages. Cells were
pretreated with apigenin (A, 25 mM) for 2 h and then treated with LPS
(100 ng/mL) for 2 h, followed by treatment with actinomycin D (5 mg/
ml). Total cellular RNA was isolated at 0, 0.5,1, 2, 4 and 6 h after
actinomycin D treatment. The mRNA levels of IL-1b and IL-6 were
determined by real-time RT-PCR as described under ‘‘METHODS’’. Values
are the means 6 S.E. from three independent experiments. A. IL-1b; B.
IL-6.
doi:10.1371/journal.pone.0107072.g013
Figure 14. Effects of apigenin on LPS-mediated mRNA
stabilization in mouse J774A.1 macrophages. Cells were pre-
treated with apigenin (A, 25 mM) for 2 h and then treated with LPS
(100 ng/mL) for 2 h, followed by treatment with actinomycin D (5 mg/
ml). Total cellular RNA was isolated at 0, 0.5,1, 2, 4 and 6 h after
actinomycin D treatment. The mRNA levels of IL-1b and IL-6 were
determined by real-time RT-PCR as described under ‘‘METHODS’’. Values
are the means 6 S.E. from three independent experiments. A. IL-1b; B.
IL-6.
doi:10.1371/journal.pone.0107072.g014
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Therefore, the NLRP3 inflammasome represents an important
therapeutic target for inflammatory diseases.
The expression of pro-inflammatory cytokines is regulated at
multiple levels, including post-transcriptional regulation by mod-
ulating mRNA stability. It has been reported that chloroquine
reduced the mRNA levels of IL-1b and IL-6 mRNA by decreasing
their stability in LPS-stimulated human monocytes/macrophages
[56]. In the present study, we also identified that post-transcrip-
tional regulation of mRNA stability also contributes to apigenin’s
anti-inflammatory activities.
Numerous studies have shown that both MAPKs and NF-kB
signaling pathways are involved in activation of an inflammatory
response [57,58]. Thus, inhibition of the LPS-stimulated signal
transduction cascades has been proposed as a promising target for
the treatment of inflammation. It has been reported that apigenin
inhibits LPS-induced inflammation through inhibition of NF-kB
activation by hypophosphorylation of Ser536 in the p65 subunit in
an in vivo mouse model [19]. Consistent with previous findings,
we also found that apigenin significantly inhibited LPS-induced
ERK1/2 and NF-kB activation in human THP-1 macrophages.
According to the previous research of the structure–activity
relationship of flavonoids and their anti-inflammatory effects, the
C2–C3 double-bond along with 4-oxo functional group of the C-
ring is essential to the higher anti-inflammatory effect. In addition,
the hydroxylations at positions 5, 7, 39, 49 are very important for
strong anti-inflammatory effects [59]. Based on the above
principles, apigenin has promising anti-inflammatory structure
(Fig.1) based on the above principles and its anti-inflammatory
effect is further verified in the current study.
Natural plants are the endless sources of medicines, which play
an essential role in healthcare. The documentation of using plant-
based medicine in health protection and disease control dates back
to thousands of years ago [60]. Recent advances in understanding
of the pathologies of various human diseases have shifted the drug
discovery paradigm from ‘‘one-disease-one-drug’’ to a ‘‘combina-
tional strategy’’, which opens up a unique opportunity for
traditional plant medicine [61–63]. During the last decade, the
pharmaceutical companies face shrinking pipelines of new drug
candidates and increasing failure of chemically synthesized drugs,
due to low efficacy and severe side effects. The focus of new drug
Figure 15. Effect of apigenin on ERK1/2 activation in human THP-1-derived macrophages. Cells were pretreated with apigenin (A, 6.25,
12.5, 25 mM) for 2 h and then treated with LPS (100 ng/mL) for 24 h. Total cell lysates were prepared for Western blot analysis for phospho(p)-ERK
and total (T)-ERK as described under ‘‘METHODS’’. The density of the immunoblots was analyzed using Odyssey V3.0 software and normalized to T-
ERK. A. Representative images of immunoblots of p-ERK1/2 and T-ERK1/2; B. Relative protein levels of p-ERK.
doi:10.1371/journal.pone.0107072.g015
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discovery efforts is shifting from the laboratory bench back to
nature. Plant medicine has been and will continue to be a rich
resource in the development of new drugs [64]. However, the
major obstacles for the advancement of plant medicine in new
drug development are a lack of scientific evidence of functional
mechanisms, unknown toxicity and uncertain drug-drug interac-
tions. Our findings in the present study provides important
scientific evidence for the potential application of apigenin as a
therapeutic agent for inflammatory diseases.
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